SONAR: Study of Diabetic Nephropathy with Atrasentan. A Randomized, Multi-country, Multi-center, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.
Aijaz Gundroo, MD Principal Investigator
Rocco C. Venuto, MD Sub-investigator
New clues to non-alcoholic fatty liver disease (NAFLD), which
affects nearly all obese adults and a rising percentage of obese
children, have been reported in a paper by senior author Susan
S. Baker MD, PhD.
Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and
Mary Bauer Professor and chair of the Department of Medicine, is a
member of the committee that has issued a new practice guideline
for treating sudden cardiac death (SCD).